Valley National Advisers’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Valley National Advisers’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	–	–	896
2019 Q4	$0	Hold	100	–	–	﹤0.01%	868
2019 Q3	$0	Buy	+100	New	+$54	﹤0.01%	861

Valley National Advisers's GCVRZ Position: Q1 2020 in Review

Valley National Advisers sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 100 shares.

Valley National Advisers first reported a position in GCVRZ in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Valley National Advisers reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Valley National Advisers sold 100 Sanofi Contingent Value Rights shares in Q1 2020.
Valley National Advisers first reported a position in Sanofi Contingent Value Rights in Q3 2019 and held it in 2 quarters.
Valley National Advisers's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Valley National Advisers's 13F filing for Q1 2020, filed 13 May 2020.